Class information for:
Level 1: METRONOMIC CHEMOTHERAPY//METRONOMIC//LOW DOSE METRONOMIC CHEMOTHERAPY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
18435 487 45.4 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
222 19941 LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METRONOMIC CHEMOTHERAPY Author keyword 93 58% 22% 107
2 METRONOMIC Author keyword 17 47% 6% 27
3 LOW DOSE METRONOMIC CHEMOTHERAPY Author keyword 6 71% 1% 5
4 GEN HOSP LIVORNO Address 3 100% 1% 3
5 METRONOMIC THERAPY Author keyword 3 29% 2% 9
6 GENET EXPT Address 3 23% 2% 10
7 METRONOMIC DOSING Author keyword 2 50% 1% 3
8 CHILDRENS CANC AUSTRALIA Address 2 15% 2% 12
9 BIOL SCI PLATFORM Address 2 36% 1% 4
10 LOW DOSE CHEMOTHERAPY Author keyword 1 17% 2% 8

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 METRONOMIC CHEMOTHERAPY 93 58% 22% 107 Search METRONOMIC+CHEMOTHERAPY Search METRONOMIC+CHEMOTHERAPY
2 METRONOMIC 17 47% 6% 27 Search METRONOMIC Search METRONOMIC
3 LOW DOSE METRONOMIC CHEMOTHERAPY 6 71% 1% 5 Search LOW+DOSE+METRONOMIC+CHEMOTHERAPY Search LOW+DOSE+METRONOMIC+CHEMOTHERAPY
4 METRONOMIC THERAPY 3 29% 2% 9 Search METRONOMIC+THERAPY Search METRONOMIC+THERAPY
5 METRONOMIC DOSING 2 50% 1% 3 Search METRONOMIC+DOSING Search METRONOMIC+DOSING
6 LOW DOSE CHEMOTHERAPY 1 17% 2% 8 Search LOW+DOSE+CHEMOTHERAPY Search LOW+DOSE+CHEMOTHERAPY
7 GL261 GLIOMA 1 100% 0% 2 Search GL261+GLIOMA Search GL261+GLIOMA
8 LIPOSOMAL ANTICANCER DRUG 1 100% 0% 2 Search LIPOSOMAL+ANTICANCER+DRUG Search LIPOSOMAL+ANTICANCER+DRUG
9 MAXIMUM TOLERATED DOSE CHEMOTHERAPY 1 100% 0% 2 Search MAXIMUM+TOLERATED+DOSE+CHEMOTHERAPY Search MAXIMUM+TOLERATED+DOSE+CHEMOTHERAPY
10 METRONOMICS 1 50% 0% 2 Search METRONOMICS Search METRONOMICS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METRONOMIC CHEMOTHERAPY 17 25% 12% 59
2 ORAL CYCLOPHOSPHAMIDE 17 31% 9% 44
3 RAT LYMPHOMA 9 83% 1% 5
4 PLUS URACIL 8 100% 1% 5
5 MAMMALIAN ANGIOGENESIS 4 75% 1% 3
6 LOW DOSE CYCLOPHOSPHAMIDE 4 12% 7% 32
7 DOSE METRONOMIC CHEMOTHERAPY 4 41% 1% 7
8 CHEMO SWITCH REGIMEN 3 57% 1% 4
9 INTERMITTENT ANDROGEN BLOCKADE 3 60% 1% 3
10 DOSE ORAL CYCLOPHOSPHAMIDE 2 50% 1% 3

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Metronomic chemotherapy: new rationale for new directions 2010 176 102 42%
Metronomics: towards personalized chemotherapy? 2014 16 180 41%
Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going? 2012 23 74 77%
The pharmacological bases of the antiangiogenic activity of paclitaxel 2013 23 72 43%
Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer 2013 14 69 55%
Low-dose metronomic chemotherapy: A systematic literature analysis 2013 21 31 39%
The anti-angiogenic basis of metronomic chemotherapy 2004 673 110 25%
Metronomic therapy and breast cancer: A systematic review 2014 3 60 55%
Metronomic chemotherapy for cancer treatment: a decade of clinical studies 2013 16 167 39%
Metronomic chemotherapy: an antiangiogenic scheduling 2007 40 48 50%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 GEN HOSP LIVORNO 3 100% 0.6% 3
2 GENET EXPT 3 23% 2.1% 10
3 CHILDRENS CANC AUSTRALIA 2 15% 2.5% 12
4 BIOL SCI PLATFORM 2 36% 0.8% 4
5 SHANGHAI HLTH SCI 1 50% 0.4% 2
6 WHO ABORATING REFERENCE VIRAL HEPATITIS 1 100% 0.4% 2
7 CRO2 RECH ONCOL BIOL ONCOPHARMACOL 1 50% 0.2% 1
8 DIPARTIMENTO ONCOL USL7 1 50% 0.2% 1
9 INSERM UNIT EPI 0113 1 50% 0.2% 1
10 INT BREAST CANC STUDY GRP CENT PATHOL OFF 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000246678 TSU 68//APATINIB//MUCOCUTANEOUS TOXICITIES
2 0.0000135384 OREGOVOMAB//AFLIBERCEPT//GI PERFORATION
3 0.0000105967 VASCULOGENIC MIMICRY//TIANJIN CANC HOSP//TEM7
4 0.0000089754 ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII
5 0.0000089247 MCA RH7777//LIVER ANGIOGRAPHY//INTERVENT RADIOL RADIOL
6 0.0000085190 MGDC//VERRUCARIN A//RADIAT TUMOR PHYSIOL
7 0.0000078738 PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR
8 0.0000078530 EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS
9 0.0000073584 ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL
10 0.0000070472 HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP